Matches in SemOpenAlex for { <https://semopenalex.org/work/W2219221010> ?p ?o ?g. }
- W2219221010 endingPage "8" @default.
- W2219221010 startingPage "282" @default.
- W2219221010 abstract "The use of epidermal growth factor receptor inhibitors (EGFRI) for the treatment of solid tumors is increasing due to elevated expression of epidermal growth factor receptors (EGFR) in the stimulation of tumor development. EGFR inhibitors have shown to be effective in the treatment of neoplasms of the head, neck, colon, and lung. Inhibition of EGFR may cause cutaneous reactions in more than 50% of patients. The most common skin manifestations are papulopustular lesions in the seborrhoeic areas (upper torso, face, neck, and scalp). Other cutaneous side effects include xerosis and hair and nail changes. The onset of eruption is usually within one to three weeks after starting therapy, although in some cases it may occur much later. All dermatologic side effects are reversible and generally resolve after adequate therapy. However, for a minority of patients side effects are severe and intolerable, demanding dose reduction or even interruption of therapy. A positive correlation has been demonstrated between the degree of cutaneous toxicity and the antitumor response. For dermatologists the goal is to provide treatment of symptoms, so that the patient may continue to benefit from the EGFRI therapy. However, frequent cutaneous manifestations, even though related to a better antitumor response, may limit use of the therapy considering the interference with patient quality of life. Early management of cutaneous side effects of EGFRI may prevent severe, extensive symptoms, the need for dose reduction, or antitumor therapy interruption. This indicates a dermatologist should play a role in early stages of treatment." @default.
- W2219221010 created "2016-06-24" @default.
- W2219221010 creator A5007850369 @default.
- W2219221010 creator A5048734238 @default.
- W2219221010 creator A5050935648 @default.
- W2219221010 creator A5062261044 @default.
- W2219221010 creator A5070566506 @default.
- W2219221010 creator A5078394749 @default.
- W2219221010 date "2015-01-01" @default.
- W2219221010 modified "2023-10-18" @default.
- W2219221010 title "The Most Common Cutaneous Side Effects of Epidermal Growth Factor Receptor Inhibitors and Their Management." @default.
- W2219221010 cites W1507522153 @default.
- W2219221010 cites W1611977008 @default.
- W2219221010 cites W1939364580 @default.
- W2219221010 cites W1959598232 @default.
- W2219221010 cites W1968151389 @default.
- W2219221010 cites W1973060721 @default.
- W2219221010 cites W1976295332 @default.
- W2219221010 cites W1978337973 @default.
- W2219221010 cites W1986744290 @default.
- W2219221010 cites W1997605441 @default.
- W2219221010 cites W2011513069 @default.
- W2219221010 cites W2033043014 @default.
- W2219221010 cites W2039633811 @default.
- W2219221010 cites W2039979010 @default.
- W2219221010 cites W2049484790 @default.
- W2219221010 cites W2058360220 @default.
- W2219221010 cites W2067946867 @default.
- W2219221010 cites W2090359261 @default.
- W2219221010 cites W2094936029 @default.
- W2219221010 cites W2118308899 @default.
- W2219221010 cites W2121275619 @default.
- W2219221010 cites W2126314379 @default.
- W2219221010 cites W2133238086 @default.
- W2219221010 cites W2147513363 @default.
- W2219221010 cites W2156757464 @default.
- W2219221010 cites W2163592822 @default.
- W2219221010 cites W2168377135 @default.
- W2219221010 cites W2361847884 @default.
- W2219221010 cites W2460495142 @default.
- W2219221010 cites W30341335 @default.
- W2219221010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26724881" @default.
- W2219221010 hasPublicationYear "2015" @default.
- W2219221010 type Work @default.
- W2219221010 sameAs 2219221010 @default.
- W2219221010 citedByCount "1" @default.
- W2219221010 countsByYear W22192210102022 @default.
- W2219221010 crossrefType "journal-article" @default.
- W2219221010 hasAuthorship W2219221010A5007850369 @default.
- W2219221010 hasAuthorship W2219221010A5048734238 @default.
- W2219221010 hasAuthorship W2219221010A5050935648 @default.
- W2219221010 hasAuthorship W2219221010A5062261044 @default.
- W2219221010 hasAuthorship W2219221010A5070566506 @default.
- W2219221010 hasAuthorship W2219221010A5078394749 @default.
- W2219221010 hasConcept C121608353 @default.
- W2219221010 hasConcept C126322002 @default.
- W2219221010 hasConcept C141071460 @default.
- W2219221010 hasConcept C16005928 @default.
- W2219221010 hasConcept C199360897 @default.
- W2219221010 hasConcept C2777329042 @default.
- W2219221010 hasConcept C2777506169 @default.
- W2219221010 hasConcept C2777673923 @default.
- W2219221010 hasConcept C2778081122 @default.
- W2219221010 hasConcept C2778515351 @default.
- W2219221010 hasConcept C2778847519 @default.
- W2219221010 hasConcept C2779438470 @default.
- W2219221010 hasConcept C2779786085 @default.
- W2219221010 hasConcept C3018411727 @default.
- W2219221010 hasConcept C3454156 @default.
- W2219221010 hasConcept C41008148 @default.
- W2219221010 hasConcept C530470458 @default.
- W2219221010 hasConcept C71924100 @default.
- W2219221010 hasConceptScore W2219221010C121608353 @default.
- W2219221010 hasConceptScore W2219221010C126322002 @default.
- W2219221010 hasConceptScore W2219221010C141071460 @default.
- W2219221010 hasConceptScore W2219221010C16005928 @default.
- W2219221010 hasConceptScore W2219221010C199360897 @default.
- W2219221010 hasConceptScore W2219221010C2777329042 @default.
- W2219221010 hasConceptScore W2219221010C2777506169 @default.
- W2219221010 hasConceptScore W2219221010C2777673923 @default.
- W2219221010 hasConceptScore W2219221010C2778081122 @default.
- W2219221010 hasConceptScore W2219221010C2778515351 @default.
- W2219221010 hasConceptScore W2219221010C2778847519 @default.
- W2219221010 hasConceptScore W2219221010C2779438470 @default.
- W2219221010 hasConceptScore W2219221010C2779786085 @default.
- W2219221010 hasConceptScore W2219221010C3018411727 @default.
- W2219221010 hasConceptScore W2219221010C3454156 @default.
- W2219221010 hasConceptScore W2219221010C41008148 @default.
- W2219221010 hasConceptScore W2219221010C530470458 @default.
- W2219221010 hasConceptScore W2219221010C71924100 @default.
- W2219221010 hasIssue "4" @default.
- W2219221010 hasLocation W22192210101 @default.
- W2219221010 hasOpenAccess W2219221010 @default.
- W2219221010 hasPrimaryLocation W22192210101 @default.
- W2219221010 hasRelatedWork W2091720022 @default.
- W2219221010 hasRelatedWork W2122899729 @default.
- W2219221010 hasRelatedWork W2219221010 @default.
- W2219221010 hasRelatedWork W2499660677 @default.